Institute for Safe Medication Practices - One of our colleagues from Germany recently reported a tragic error involving fentanyl nasal spray to ISMP. A 28 year-old male accidentally took 2 puffs of
![Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS) Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS)](https://www.peertechz.com/images/advertisement-call-for-papers-peertechz-open-access-journals-hbanner.jpg)
Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS)
![References in Pharmacokinetics of intranasal fentanyl in parturient - British Journal of Anaesthesia References in Pharmacokinetics of intranasal fentanyl in parturient - British Journal of Anaesthesia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2117039782/2085320704/gr1.jpg)
References in Pharmacokinetics of intranasal fentanyl in parturient - British Journal of Anaesthesia
![PDF] Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS) | Semantic Scholar PDF] Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e5573a239fec25e1b680aba2f66032e06ba9928e/4-Table1-1.png)
PDF] Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS) | Semantic Scholar
![PDF] Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS) | Semantic Scholar PDF] Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e5573a239fec25e1b680aba2f66032e06ba9928e/2-Figure1-1.png)
PDF] Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS) | Semantic Scholar
![The Prevalence of Off-label Prescribing of Transmucosal Immediate-Release Fentanyl in France - Journal of Pain and Symptom Management The Prevalence of Off-label Prescribing of Transmucosal Immediate-Release Fentanyl in France - Journal of Pain and Symptom Management](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/1f0e27fa-0319-4a99-a155-6e1f7a121d22/gr1.jpg)
The Prevalence of Off-label Prescribing of Transmucosal Immediate-Release Fentanyl in France - Journal of Pain and Symptom Management
FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
![Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS) Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS)](https://www.peertechzpublications.com/Anesthesiology/images/GJA-1-104-g003.gif)